Application 218282
- Type
- ANDA
- Sponsor
- EIRGEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 25MG | No | No |
| 002 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 50MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218282-001 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2024-12-03 | |
| A218282-002 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2024-12-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218282-001 | AB |
| A218282-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218282-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2024-12-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218282-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2024-12-03 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218282-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2024-12-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218282-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2024-12-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218282-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2024-12-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218282-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2024-12-03 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218282-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2024-12-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218282-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2024-12-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218282-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2024-12-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218282-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2024-12-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218282-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2024-12-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218282-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2024-12-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218282-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2024-12-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218282-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2024-12-03 | 2680178bc6a6… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218282-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2024-12-03 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218282-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2024-12-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218282-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218282-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218282-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218282-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A218282-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A218282-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218282-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218282-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218282-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218282-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218282-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218282-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218282-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218282-002 | AB | 1 | 2680178bc6a6… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218282-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218282-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cyclophosphamide | CYCLOPHOSPHAMIDE | OPKO Pharmaceuticals, LLC | d8057d1a-e8af-42ab-9da2-b545730b2655 | 2026-05-04 | Warnings, Adverse reactions | 218282 ANDA218282 |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | OPKO Pharmaceuticals, LLC | 7d6447e3-22c9-48d9-87c0-d0b576d7ea9e | 2026-04-21 | Warnings, Adverse reactions | 218282 ANDA218282 |